Literature DB >> 12384932

Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis.

Margherita Massa1, Federica Mazzoli, Patrizia Pignatti, Fabrizio De Benedetti, Maristella Passalia, Stefania Viola, Rodrigo Samodal, Antonio La Cava, Francesca Giannoni, W Ollier, Alberto Martini, Salvatore Albani.   

Abstract

OBJECTIVE: To evaluate whether abnormal T cell recognition may be generated by exposure to exogenous antigens presenting sequence homology with epitopes contained in self HLA alleles, and if such recognition may be part of the mechanisms that fuel inflammation in autoimmune diseases associated with certain HLA alleles.
METHODS: Cytotoxic responses of peripheral blood mononuclear cells to 9-mer peptides derived from HLA molecules (DRB1*1101, DRB1*0801, or DPB1*0201) associated with oligoarticular juvenile idiopathic arthritis (JIA) or homologous peptides derived from Epstein-Barr virus (EBV) proteins (Bolf1 or Balf2) were analyzed in patients with oligoarticular JIA and in healthy controls matched for HLA-DRB1*1101, DRB1*0801, or DPB1*0201. Production of proinflammatory cytokines in culture supernatants was determined by enzyme-linked immunosorbent assay.
RESULTS: T cell cytotoxic responses and production of proinflammatory cytokines in response to stimulation with self HLA-derived peptides were found only in patients with oligoarticular JIA, and not in controls. Patients with oligoarticular JIA, but none of the healthy controls, had EBV-self HLA cross-reactive T cells.
CONCLUSION: Our data suggest a disease- and allele-specific mechanism of autoimmunity in oligoarticular JIA. This mechanism may be part of the pathogenesis of the disease, and could be the basis of one of the likely multiple candidates for antigen-specific immunotherapy approaches in the future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384932     DOI: 10.1002/art.10564

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study.

Authors:  Daniel B Horton; Frank I Scott; Kevin Haynes; Mary E Putt; Carlos D Rose; James D Lewis; Brian L Strom
Journal:  Pediatrics       Date:  2015-07-20       Impact factor: 7.124

Review 2.  [Concepts on the pathogenesis of juvenile idiopathic arthritis].

Authors:  T Niehues; O Feyen; T Telieps
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

3.  Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis.

Authors:  Anna Corcione; Francesca Ferlito; Marco Gattorno; Andrea Gregorio; Angela Pistorio; Roberto Gastaldi; Claudio Gambini; Alberto Martini; Elisabetta Traggiai; Vito Pistoia
Journal:  Arthritis Res Ther       Date:  2009-10-05       Impact factor: 5.156

Review 4.  Oligoarticular and polyarticular JIA: epidemiology and pathogenesis.

Authors:  Claudia Macaubas; Khoa Nguyen; Diana Milojevic; Jane L Park; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

Review 5.  Autoimmune disorders: a concept of treatment based on mechanisms of disease.

Authors:  Peter A Miescher; Laura Zavota; Alejandra Ossandon; Bruno Lagana
Journal:  Springer Semin Immunopathol       Date:  2003-11-06

6.  Epstein-barr virus as a trigger of autoimmune liver diseases.

Authors:  Eirini I Rigopoulou; Daniel S Smyk; Claire E Matthews; Charalambos Billinis; Andrew K Burroughs; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Adv Virol       Date:  2012-05-28

Review 7.  The Etiology of Juvenile Idiopathic Arthritis.

Authors:  Donato Rigante; Annalisa Bosco; Susanna Esposito
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 10.817

8.  Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.

Authors:  Sylvia Kamphuis; Kolbrún Hrafnkelsdóttir; Mark R Klein; Wilco de Jager; Margje H Haverkamp; Jolanda H M van Bilsen; Salvatore Albani; Wietse Kuis; Marca H M Wauben; Berent J Prakken
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Abatacept in difficult-to-treat juvenile idiopathic arthritis.

Authors:  Jasmin B Kuemmerle-Deschner; Sm Benseler
Journal:  Biologics       Date:  2008-12

Review 10.  A complex interaction between drug allergy and viral infection.

Authors:  Tetsuo Shiohara; Yoko Kano
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.